Physician profile
Omar Ali
NPI 1437545050
$66,640.92
in general payments reported to CMS, 2019-2025
32 companies · $1,562 in 2025
The $1,562 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $1,705 · 2021: $1,969 · 2022: $1,125 · 2023: $1,310 · 2024: $2,208 · 2025: $1,562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,779 · Education: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,779.39 |
| Education | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $49,503.60 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Superion Indirect Decompression System |
| Medtronic USA, INC. | $11,326.09 | 2019 | |
| Vertos Medical, INC. | $1,050.84 | 2020-2024 | Mild Device Kit |
| Abbott Laboratories | $1,009.67 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $505.49 | 2020-2025 | Xtampza |
| Stryker Corporation | $406.27 | 2024-2025 | Mild Device Kit |
| Biotronik Nro, INC. | $402.97 | 2025 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $399.66 | 2021-2025 | Relistor |
| Straumann USA LLC | $300.00 | 2024 | |
| Amgen INC. | $206.30 | 2020-2024 | Krystexxa |
| Spr Therapeutics, INC | $196.22 | 2022-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $158.72 | 2024-2025 | Evoke |
| Medtronic, INC. | $150.52 | 2023-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Tersera Therapeutics LLC | $139.79 | 2021-2025 | Prialt |
| Vertex Pharmaceuticals Incorporated | $127.56 | 2024-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flowonix Medical Incorporated | $123.74 | 2020 | |
| Spinefrontier, INC. | $115.38 | 2020 | |
| Lundbeck LLC | $83.87 | 2022-2024 | Vyepti |
| Avanos Medical | $63.94 | 2019 | |
| Abbvie INC. | $52.28 | 2021-2022 | |
| Pfizer INC. | $48.36 | 2020-2021 | |
| Stimwave Technologies Incorporated | $46.02 | 2022 | |
| Curonix LLC | $36.16 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Valinor Pharma, LLC | $30.21 | 2025 | Movantik |
| Lilly USA, LLC | $29.54 | 2021 | |
| Tonix Medicines, INC. | $26.92 | 2025 | Tonmya |
| Arbor Pharmaceuticals, INC. | $22.54 | 2021 | |
| Convatec INC. | $17.91 | 2023 | |
| Si-Bone, INC. | $16.73 | 2022 | |
| Spinal Simplicity, LLC | $15.06 | 2022 | |
| Ibsa Pharma INC. | $14.91 | 2021 | |
| Scilex Pharmaceuticals INC. | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.